Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2026-01-15 @ 5:59 PM
Study NCT ID:
NCT01113502
Status:
TERMINATED
Last Update Posted:
2021-08-05
First Post:
2010-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UPCC 17409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None